Jonathan Newmark M.D., M.M., FAAN

Education

A. B. magna cum laude, Harvard College, Cambridge, Massachusetts, 1974
M.D., College of Physicians and Surgeons, Columbia University, New York, New York, 1978
M.M., College-Conservatory of Music, University of Cincinnati, Cincinnati, Ohio, 2015

Biography

COL (ret.) Newmark was born in New York City in 1953. A 1974 graduate of Harvard College, he earned his MD from Columbia University College of Physicians and Surgeons in 1978. He completed an internship at Roosevelt Hospital, New York, neurology residency at the Boston City Hospital, Boston, Massachusetts, and fellowships in neurobiochemistry at the National Institute of Neurological Disorders and Stroke, Bethesda, Maryland, in EMG and neuromuscular medicine at the Hospital of the University of Pennsylvania, Philadelphia, and in occupational neurology at the Massachusetts General Hospital, Boston.
He joined the US Army Reserve in 1989, and held Reserve assignments at:
5010th US Army Hospital, Louisville, Kentucky
348th General Hospital, Folsom, Pennsylvania
First US Army Physician Management Branch, Fort George G. Meade, Maryland
He also deployed on a humanitarian assistance mission to Belize in 1993.
He joined the active Army in 1993, retiring as a colonel in 2013 after assignments as:
Chief, outpatient neurology, Madigan Army Medical Center, Fort Lewis, Washington
Chief, operations, Chemical Casualty Care, US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Maryland
Deputy Joint Program Executive Officer for Medical Systems, Joint Program Executive Office for Chemical/Biological Defense, Falls Church, Virginia
He deployed for six months as deputy surgeon, Task Force 2-1 (ADA) to Saudi Arabia, and served shorter deployments to Kosovo, Bahrain, Kuwait, Afghanistan, and Korea.
He is a board-certified neurologist, staff neurologist at the Washington DC VA Medical Center, full professor of neurology at USUHS, clinical assistant professor of neurology at George Washington University School of Medicine and Health Sciences, former (2002-2012) Chemical Casualty Care Consultant to the Army Surgeon General, and one of the nation’s authorities on medical response to chemical warfare and terrorism. In 2018 he was appointed by Virginia Governor Ralph Northam to a four-year term on the Secure and Resilient Commonwealth Panel of Virginia; he was reappointed by Governor Glenn Youngkin in 2022. Since 2019 he has served as Senior Medical Advisor, Office of Biodefense Research and Surety, National Institute of Allergy and Infectious Diseases, National Institutes of Health, helping to administer the country's civilian medical chemical defense program. He lives in Burke, Virginia.

Career Highlights: Positions, Projects, Deployements, Awards and Additional Publications

Only military neurologist to address American Academy of Neurology annual meeting in uniform, 2002

Only neurologist in the medical chemical/biological defense program, 1997-present

Representative Bibliography

Newmark J, Romano JA. Chemical warfare agents. In Fauci AS et al., eds. Harrison’s Principles of Internal Medicine, Twenty-first Edition. New York: McGraw-Hill, in press 2021

Cieslak TJ, Newmark J. Biological and chemical terrorism. In: Kliegman RM, S. Geme JW, Blum NJ, Shah SS, Tasker RC and Wilson KM, eds. Nelson’s Textbook of Pediatrics, 21st edition. Philadelphia: Elsevier, 2019, volume 2, chapter 741, pp. 3806-3815

Newmark J. Therapy for acute nerve agent poisoning: an update. Neurol Clin Pract 9(4):337-342, 2019.

Newmark J. Clinical aspects of large-scale chemical events. In: Koenig KL and Schultz CH, eds. Koenig and Schultz’s Disaster Medicine: Comprehensive Principles and Practices, second edition. New York: Cambridge University Press, 2016, pp. 500-522

Loh Y, Swanberg MM, Ingram MV, Newmark J. Case report: long term cognitive sequelae of sarin exposure. Neurotoxicology 31:244-246, 2010

Newmark J. Neurological problems of famous musicians: the classical genre. J Child Neurol 24:1043-1050, 2009

Newmark HL, Newmark J. Vitamin D and Parkinson’s disease: an hypothesis. Movement Disorders 22(4):461-468, 2007

Newmark J, Langer JM, Capacio B, Barr J, McIntosh RG. Liquid sulfur mustard exposure. Military Medicine 172:196-199, 2007

Anderson DR, Holmes WW, Lee RB, Dalal SJ, Hurst CG, Maliner, BI, Newmark J, Smith WJ. Sulfur mustard-induced neutropenia: treatment with granulocyte colony stimulating factor. Military Medicine 171:448-453, 2006

Newmark J. The birth of nerve agent warfare: lessons from Syed Abbas Foroutan. Neurology 62:1590-1596, 2004